Primary central nervous system lymphoma in immunocompetent individuals: a single center experience

Area of Science:

• Neuro-oncology
• Hematology
• Clinical research

Background:

• Primary central nervous system lymphoma (PCNSL) is a rare non-Hodgkin lymphoma affecting the brain, leptomeninges, eyes, or spinal cord.
• The prognostic significance of various markers in PCNSL remains under investigation.
• Immunocompetent PCNSL cases represent a specific subgroup requiring dedicated analysis.

Purpose of the Study:

• To analyze clinical and immunohistochemical features of immunocompetent PCNSL.
• To evaluate the impact of prognostic factors on overall survival (OS) in PCNSL patients.
• To identify potential therapeutic strategies for improving PCNSL outcomes.

Main Methods:

• Retrospective analysis of 39 immunocompetent PCNSL cases.
• Collection of data on patient demographics, neuroimaging, pathology, and immunohistochemistry.
• Statistical analysis using log-rank test and Cox regression to assess OS predictors.

Main Results:

• Combined chemotherapy and radiotherapy significantly improved OS compared to chemotherapy alone.
• No significant survival advantage was observed for other investigated clinicopathological variables.
• The study identified a potential benefit of combined modality treatment in PCNSL.

Conclusions:

• The study did not establish a definitive link between most clinicopathological variables and PCNSL patient OS.
• Combined chemotherapy and radiotherapy appears to be a beneficial treatment approach.
• Larger prospective studies are necessary to elucidate other prognostic factors in PCNSL.